Bioduro

中文简体

Let's talk
Contact us

Embedded in everything we do at BioDuro is the reality that the product we help create has the potential to cure patients.

Masood Tayebi, Founder and Chairman

Masood Tayebi, Ph.D.

Chairman and Founder

Embedded in everything we do at BioDuro is the reality that the product we help create has the potential to cure patients. It’s that constant reminder that motivates us to transform the way pharmaceuticals are made. From drug substance to drug product, discovery to development, small molecule or biologics, BioDuro’s solutions provide pharmaceutical and biopharmaceutical companies with the quality results they need to help deliver their drugs to patients.

The Proof is in the Data

12 years as a trusted partner

  • 2005

    BioDuro is founded in California with investment from Biotech Investment Group, a San Diego private equity firm. BioDuro begins CRO service operations in Beijing.

  • 2009

    BioDuro expands to more than 600 employees in its Beijing facility, and becomes part of PPD’s global CRO services later that year.

  • 2012

    BioDuro opens a 92,000 square-foot state-of-the-art lab in Shanghai to meet increasing client demand for DMPK, bioanalytical, chemistry, discovery biology and pharmacology services.

  • 2013

    Formex joins the Biotech Investment Group family, operating in a 44,000 square foot formulation development and cGMP manufacturing facility in the Torrey Pines biotech hub of San Diego.

  • 2015

    BioDuro is reacquired from PPD. BioDuro and Formex merge to enable service offerings that span from API synthesis to formulation development and cGMP manufacture of drug product.